Skip to main content
Clinical Trials/NCT04316325
NCT04316325
Completed
Not Applicable

Medical Abortion Via Telemedicine for Women and Adolescents in Moldova

Reproductive Health Training Center of the Republic of Moldova1 site in 1 country549 target enrollmentMarch 20, 2020
ConditionsPregnancy
InterventionsMedical abortion

Overview

Phase
Not Applicable
Intervention
Medical abortion
Conditions
Pregnancy
Sponsor
Reproductive Health Training Center of the Republic of Moldova
Enrollment
549
Locations
1
Primary Endpoint
Successful termination of pregnancy without adverse events
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study evaluates the safety, feasibility, and acceptability of a novel medical abortion via telemedicine service in the Republic of Moldova.

Detailed Description

Women and girls in Moldova, especially those in rural areas, must travel to regional medical centers to obtain an abortion from a certified gynecologist. This creates barriers to accessing safe abortion that disproportionately affect poor women and girls, through wage loss due to missed work and accrued costs due to transportation. This innovation is a novel service delivery model that allows self-management of medical abortion (MA) with remote guidance from a provider. After confirming their pregnancy, women seeking MA will receive counseling from a gynecologist via videoconference and will subsequently obtain the necessary medication via mail or at at participating pharmacy with prescription. Follow-up will occur 1 weeks later via phone/videoconference (with referral to a doctor if necessary) to confirm MA success and assess the patient's and provider's satisfaction with the service. We hope to demonstrate the feasibility, effectiveness and acceptability of telemedicine MA services in Moldova so that it can thus be integrated into the national public healthcare system. As a result, this project will serve as a model that could be adapted and implemented in nearby countries within the Eastern Europe and Central Asia region.

Registry
clinicaltrials.gov
Start Date
March 20, 2020
End Date
March 31, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Reproductive Health Training Center of the Republic of Moldova
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 16 years or older
  • Has an unwanted pregnancy
  • Confirmed the pregnancy using a test or via ultrasound
  • Gestational age of 9 weeks or less
  • Has personally decided to end the pregnancy
  • Has a device (phone, tablet, or computer) with internet connection, a webcam, and a microphone.
  • Has immediate access to emergency services
  • Reports no contraindication to medical abortion

Exclusion Criteria

  • Under 16 years of age
  • Does not have an unwanted pregnancy
  • Did not confirm pregnancy
  • Gestational age greater than 9 weeks
  • Does not have a device (phone, tablet, or computer) with internet connection, a webcam, and a microphone
  • Does not have immediate access to emergency services
  • Has an intrauterine device
  • Is allergic to abortion medications (mifepristone or misoprostol)
  • Has severe anemia or acute porphyria
  • Has a condition that affects the ability of blood to clot normally

Arms & Interventions

Women and girls seeking abortion.

Intervention: Medical abortion

Outcomes

Primary Outcomes

Successful termination of pregnancy without adverse events

Time Frame: through study completion, around 15 months

Percentage of study participants that successfully terminate their pregnancy via the telemedicine medical abortion model without experiencing any adverse events.

Secondary Outcomes

  • Participant satisfaction with the medical abortion via telemedicine service(through study completion, around 15 months)
  • Cost savings experienced by study participants(through study completion, around 15 months)
  • Provider satisfaction(through study completion, around 15 months)

Study Sites (1)

Loading locations...

Similar Trials